Abstract
Epstein-Barr virus (EBV) has been linked to infectious mononucleosis and to the neoplasias, nasopharyngeal carcinoma and Burkitt’s lymphoma. The initial evidence of an etiologic relationship was mainly derived from seroepidemiological studies (for review see ref. 1) and confirmed by nucleic acid hybridization with biopsy materials (for review see ref. 2). The work of many laboratories contributed data which does not seem to fit into a unifying concept. This paper briefly summarizes some apparently conflicting results; from these data a hypothetical model for the biology of EBV is developed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Henle, W. and Henle, G. Seroepidemiology of the virus. In: M.A. Epstein and B.G. Achong (eds.), The Epstein-Barr Virus. pp. 62–78. New York: Springer, 1979.
Wolf, H. The biology of Epstein-Barr virus (EBV) in relation to NPC. In: Proceedings of UICC Workshop on Nasopharyngeal Carcinoma, in print, 1982.
Bayliss, C.G. and Wolf, H. The regulated expression of Epstein-Barr virus. III. Proteins specific by EBV during the lytic cycle. J. Virol., 56:105, 1981.
Jondal, M. and Klein, G. Surface markers on human B and T lymphocytes. II. Presence of Epstein-Barr virus receptors on B lymphocytes. J. Exp. Med., 138:1365, 1973.
Glaser, R., Lang, C.M., Lee, K.J., Schuller, D.E., Jacobs, D., and McQuattie, C Attempt to infect nonmalignant nasopharyngeal epithelial cells from humans and squirrel monkeys with Epstein-Barr virus. J. Natl. Cancer Inst., 64:1085, 1980.
Wolf, H. and zur Hausen, H. unpublished.
Wolf, H., zur Hausen, H., and Becker, V. EB viral genomes in epithelial nasopharyngeal carcinoma cells. Nature New Biol., 244:245, 1973.
Desgranges, C., Wolf, H., de Thé, G., Shanmugaratnam, K., Cammoun, N., Ellouz, R., Klein, G., Lennert, K., Munoz, N., and zur Hausen, H. Nasopharyngeal carcinoma. X. Presence of Epstein-Barr genomes in separated epithelial cells of tumors in patients from Singapore, Tunisia and Kenya. Int. J. Cancer, 16: 7, 1975.
Klein, G., Giovanella, B.C., Lindahl, T., Fialkov, P.J., Singh, S., and Stehlin, J. Direct evidence for the presence of Epstein-Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with poorly differentiated carcinoma of the nasopharynx. Proc. Natl. Acad. Sci. USA, 71:4737, 1974.
Bornkamm, G.W., Delius, H., Zimber, U., Hudewentz, J., and Epstein, M.A. Comparison of Epstein-Barr virus strains of different origin by analysis of the viral DNAs. J. Virol., 35:603, 1980.
Modrow, S. and Wolf, H. Characterization of Herpesvirus saimiri and Herpesvirus ateles induced proteins. J. Gen. Virol., in press.
Wilmes, E. and Wolf, H. Der Nachweis von Epstein-Barr-virus-genomen in der Orhspeicheldruse. Laryngol-Rhinol., 60:7, 1981.
Wolf, H., Wilmes, E., and Bayliss, G.J. Epstein-Barr virus: its site of persistence and its role in the development of carcinomas. In: Neth et al. (eds.), Modern Trends in Human Leukemia IV. pp. 191–196. Heidelberg, Berlin: Springer, 1981.
Bayliss, G.J. and Wolf, H. Epstein-Barr virus-induced cell fusion. Nature, 287;164, 1980.
Bayliss, C.J. and Wolf, H. An Epstein-Barr virus early protein induces cell fusion. Proc. Natl. Acad. Sci. USA, 78: 7162, 1981.
Wolf, H., Bayliss, G.J., and Wilmes, E. Biological properties of Epstein-Barr virus. In: E. Grundmann, G.R.F. Krueger, and D.V. Ablashi (eds.), Nasopharyngeal Carcinoma. Vol. 5, pp. 101–109. Gustav Fischer Verlag -Stuttgart, 1981.
Döhnert, C. Ober lymphoepitheliale guschwulste Erkenntnisse anhand der Gewekultur und vergleichender klinischer, morphologischer under virologischer Untersuchungen. In: Sitzungsbericht der Heidelberger Akademie der Wissenschaften. Vol 3, pp. 96–168. Berlin:Springer, 1977.
Hirayama, T. and Ito, Y. A new view of the etiology of nasopharyngeal carcinoma. Preventive Medicine, 10: 614, 1981.
Wilmes, E., Wolf, H., Deinhardt, F. and Naumann, H.H. EBV serology in NPC and related malignancies. In: E. Grundman, G.R.F. Krueger, and D.V. Ablashi (eds.), Cancer Campaign. Nasopharyngeal Carcinoma. Vol. 5, pp. 145–150. Gustav Fischer Verlag — Stuttgart, 1981.
Glaser, R., Zimmermann, J., St. Jeor, S., and Rapp, F. Demonstration of a cellular inhibitor of Epstein-Barr and cytomegalovirus synthesis. Virology, 64:289, 1975.
Graessmann, A., Wolf, H., and Bornkamm, G.W. Expression of Epstein-3arr virus genes in different cell types after microinjection of viral DNA. Proc. Natl. Acad. Sci. USA, 77:433, 1980.
Birnboim, H.C. DNA strand breakage in human leukocytes exposed to a tumour promoter, phorbol myristate acetate. Science, 215:1247, 1982.
Burkitt, D.P. Etiology of Burkitt’s lymphoma — an alternative hypothesis to a vectored virus. J. Natl. Cancer Inst., 42:19, 1969.
Manolova, Y., Manolov, G., Keiler, J., Levan, A., and Klein, G. Pseudo-Burkitt lymphoma marker 14 in lymphoblastoid cell lines. Hereditas, 90:5, 1979.
Klein, G. Lymphoma development in mice and humans: diversity of initiation is followed by convergent cytogenetic evolution. Proc. Natl. Acad. Sci. USA, 76:1221, 1979.
Purtilo, D.T. Epstein-Barr-virus-induced oncogenesis in immune-deficient individuals. Lancet, i: 300, 1980.
Purtilo, D.T. Immune deficiency predisposing to Epstein-Barr virus-induced lymphoproliferative diseases: the X-linked lymphoproliferative syndrome as a model. In: G. Klein and S. Weinhouse (eds.), Advances in Cancer Research. Vol. 34, pp. 279–312. New York: Academic Press, 1980.
Morgan, D.G., Miller, G., Niedermann, J.C., Smith, H.W., and Dowaliby, J.M. Site of Epstein-Barr virus replication in the oropharynx. Lancet, ii:1154, 1979.
Wolfe, II., Haus, M., and Wilmes, E. Submitted.
zur Hausen, H., Bornkamm, G.W., Schmidt, R., and Hecker, E. Tumor initiators and promoters in the induction of Epstein-Barr virus. Proc. Natl. Acad. Sci. USA, 76:782, 1979.
Institute of Virology, Beijing. A study on the serum level of complement fixing antibody to EB virus in groups of individuals of Guangdong province and Beijing. Chinese J. Otorhinolaryngol., 13:23, 1978.
Jaenisch, R. Retroviruses and embryogenes is: microinjection of Moloney leukemia virus into midges tation mouse embryos. Cell, 19:181, 1980.
Seigneurin, J.-M., Vuillaume, M., Lenoir, G., and de The, G. Replication of Epstein-Barr virus: ultrastructural and immunofluorescent studies of P3HRl-superinfected Raji cells. J. Virol., 24:836, 1977.
Finerty, S., Jarvis, J.E., Epstein, M.A., Tramper, P.A., Ball, G., and Giovanella, B.C. Cytogenetics of malignant epithelial cells and lymphoblastoid cell lines from nasopharyngeal carcinoma. Br. J. Cancer, 37:231, 1978.
Glaser, R., de The, G., Lenoir, G., and Ho, J.H. Superinfection of epithelial nasopharyngeal carcinoma cells with Epstein-Barr virus. Proc. Natl. Acad. Sci. USA, 73:960, 1976.
Kintner, C.H. and Sugden, B. Identification of antigenic determinants unique to the surfaces of cells transformed by Epstein-Barr virus. Nature, 294:458, 1981.
Reitz, M.S., Jr., Popovic, M., Kalyanaraman, V.S., Robert-Guroff, M., Broder, S., Mann, D., and Gallo, R.C. Human T-cell leukemia-lymphoma virus (HTLV): presence in a T-cell subset from infected patients. In: R. Neth, R. Gallo, T. Graf, K. Mannweiler, and K. Winkler (eds.), Modern Trends in Human Leukemia. Vol. IV. Berlin: Springer-Verlag, in press.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Plenum Publishing Corporation
About this chapter
Cite this chapter
Wolf, H. (1984). Biology of Epstein-Barr Virus. In: Purtilo, D.T. (eds) Immune Deficiency and Cancer. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4760-6_11
Download citation
DOI: https://doi.org/10.1007/978-1-4684-4760-6_11
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-4762-0
Online ISBN: 978-1-4684-4760-6
eBook Packages: Springer Book Archive